FDA approvals usher in the post-interferon era in HCV
- PMID: 24406908
- DOI: 10.1038/nbt0114-3
FDA approvals usher in the post-interferon era in HCV
Similar articles
-
New drugs: simeprevir, sofosbuvir, and dolutegravir sodium.J Am Pharm Assoc (2003). 2014 Mar-Apr;54(2):202-7. doi: 10.1331/JAPhA.2014.14513. J Am Pharm Assoc (2003). 2014. PMID: 24632934 No abstract available.
-
Sofosbuvir, simeprevir, and ribavirin for the treatment of hepatitis C virus recurrence in human immunodeficiency virus/hepatitis C virus-coinfected liver transplant recipients.Liver Transpl. 2015 Feb;21(2):272-4. doi: 10.1002/lt.24027. Liver Transpl. 2015. PMID: 25332190 Free PMC article. No abstract available.
-
WHO issues guidelines on HCV amid drug cost controversy.JAMA. 2014 Jun 11;311(22):2262-3. doi: 10.1001/jama.2014.5277. JAMA. 2014. PMID: 24915242 No abstract available.
-
Second-wave IFN-based triple therapy for HCV genotype 1 infection: simeprevir, faldaprevir and sofosbuvir.Liver Int. 2014 Feb;34 Suppl 1:60-8. doi: 10.1111/liv.12424. Liver Int. 2014. PMID: 24373080 Review.
-
How to optimize current therapy in hepatitis C virus genotype 1 patients. Predictors of response to interferon-based therapy with second wave direct acting antivirals.Liver Int. 2015 Jan;35 Suppl 1:18-20. doi: 10.1111/liv.12722. Liver Int. 2015. PMID: 25529083 Review.
Cited by
-
Industry chases pan-genotypic and shorter HCV treatments.Nat Biotechnol. 2015 Jun;33(6):575-6. doi: 10.1038/nbt0615-575. Nat Biotechnol. 2015. PMID: 26057958 No abstract available.
-
Sovaldi makes blockbuster history, ignites drug pricing unrest.Nat Biotechnol. 2014 Jun;32(6):501-2. doi: 10.1038/nbt0614-501. Nat Biotechnol. 2014. PMID: 24911474 No abstract available.
-
Measuring fate and rate of single-molecule competition of amplification and restriction digestion, and its use for rapid genotyping tested with hepatitis C viral RNA.Angew Chem Int Ed Engl. 2014 Jul 28;53(31):8088-8092. doi: 10.1002/anie.201403035. Epub 2014 Jun 2. Angew Chem Int Ed Engl. 2014. PMID: 24889060 Free PMC article.
-
A Cost-Utility Analysis of Different Antiviral Medicine Regimens in Patients With Chronic Hepatitis C Virus Genotype 1 Infection.Iran Red Crescent Med J. 2016 Oct 2;18(11):e37094. doi: 10.5812/ircmj.37094. eCollection 2016 Nov. Iran Red Crescent Med J. 2016. PMID: 28203449 Free PMC article.
-
Efficient Synthesis and Docking Studies of Novel Benzothiazole-Based Pyrimidinesulfonamide Scaffolds as New Antiviral Agents and Hsp90α Inhibitors.ACS Omega. 2020 Jan 9;5(3):1640-1655. doi: 10.1021/acsomega.9b03706. eCollection 2020 Jan 28. ACS Omega. 2020. PMID: 32010839 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical